AAAAAA

   
Results: 1-9 |
Results: 9
EXPERIENCE OF THE POLYCYTHEMIA-VERA STUDY-GROUP WITH ESSENTIAL THROMBOCYTHEMIA - A FINAL REPORT ON DIAGNOSTIC-CRITERIA, SURVIVAL, AND LEUKEMIC TRANSITION BY TREATMENT
Authors: MURPHY S PETERSON P ILAND H LASZLO J
Citation: S. Murphy et al., EXPERIENCE OF THE POLYCYTHEMIA-VERA STUDY-GROUP WITH ESSENTIAL THROMBOCYTHEMIA - A FINAL REPORT ON DIAGNOSTIC-CRITERIA, SURVIVAL, AND LEUKEMIC TRANSITION BY TREATMENT, Seminars in hematology, 34(1), 1997, pp. 29-39
A DOSE-ESCALATION STUDY OF HIGH-DOSE INTERFERON-ALPHA 2A (HDIFN) UP TO 18 MILLION UNITS DAILY IN PATIENTS WITH POOR-PROGNOSIS CHRONIC MYELOID-LEUKEMIA (CML) OR GOOD PROGNOSIS PATIENTS WHO HAVE FAILED TREATMENTWITH IFN PLUS CYTOSINE-ARABINOSIDE (ARA-C)
Authors: ARTHUR CK ENNO A FIRKIN F MA D ILAND H CONCANNON A YOUNG G SHAW P GALLO J HERTZBERG M
Citation: Ck. Arthur et al., A DOSE-ESCALATION STUDY OF HIGH-DOSE INTERFERON-ALPHA 2A (HDIFN) UP TO 18 MILLION UNITS DAILY IN PATIENTS WITH POOR-PROGNOSIS CHRONIC MYELOID-LEUKEMIA (CML) OR GOOD PROGNOSIS PATIENTS WHO HAVE FAILED TREATMENTWITH IFN PLUS CYTOSINE-ARABINOSIDE (ARA-C), Blood, 88(10), 1996, pp. 2291-2291
SSCP DETECTION OF N-RAS PROMOTER MUTATIONS IN AML PATIENTS
Authors: THORN J MOLLOY P ILAND H
Citation: J. Thorn et al., SSCP DETECTION OF N-RAS PROMOTER MUTATIONS IN AML PATIENTS, Experimental hematology, 23(10), 1995, pp. 1098-1103
A RANDOMIZED DOSAGE STUDY OF CEFTAZIDIME WITH SINGLE DAILY TOBRAMYCINFOR THE EMPIRICAL MANAGEMENT OF FEBRILE NEUTROPENIA IN PATIENTS WITH HEMATOLOGICAL DISEASES
Authors: GIBSON J JOHNSON L SNOWDON L JOSHUA D YOUNG G MACLEOD C ILAND H VINCENT P KRONENBERG H
Citation: J. Gibson et al., A RANDOMIZED DOSAGE STUDY OF CEFTAZIDIME WITH SINGLE DAILY TOBRAMYCINFOR THE EMPIRICAL MANAGEMENT OF FEBRILE NEUTROPENIA IN PATIENTS WITH HEMATOLOGICAL DISEASES, International journal of hematology, 60(2), 1994, pp. 119-127
TRENDS IN BACTERIAL-INFECTIONS IN FEBRILE NEUTROPENIC PATIENTS - 1986-1992
Authors: GIBSON J JOHNSON L SNOWDON L JOSHUA D YOUNG G MACLEOD G BENN R ILAND H VINCENT P KRONENBERG H
Citation: J. Gibson et al., TRENDS IN BACTERIAL-INFECTIONS IN FEBRILE NEUTROPENIC PATIENTS - 1986-1992, Australian and New Zealand Journal of Medicine, 24(4), 1994, pp. 374-377
SINGLE DAILY CEFTRIAXONE AND TOBRAMYCIN IN THE EMPIRICAL MANAGEMENT OF FEBRILE NEUTROPENIC PATIENTS - A RANDOMIZED TRIAL
Authors: GIBSON J JOHNSON L SNOWDON L JOSHUA D YOUNG G MACLEOD C SADER C ILAND H VINCENT P KRONENBERG H
Citation: J. Gibson et al., SINGLE DAILY CEFTRIAXONE AND TOBRAMYCIN IN THE EMPIRICAL MANAGEMENT OF FEBRILE NEUTROPENIC PATIENTS - A RANDOMIZED TRIAL, International journal of hematology, 58(1-2), 1993, pp. 63-72
C-FMS POINT MUTATIONS IN ACUTE MYELOID-LEUKEMIA - FACT OR FICTION
Authors: SPRINGALL F OMARA S YI SN TODD A FORD D ILAND H
Citation: F. Springall et al., C-FMS POINT MUTATIONS IN ACUTE MYELOID-LEUKEMIA - FACT OR FICTION, Leukemia, 7(7), 1993, pp. 978-985
TRANSFORMATION OF PITUITARY AND FIBROBLAST CELL-LINES USING HUMAN INSULIN C-DNA AND A DEXAMETHASONE-INDUCIBLE PROMOTER
Authors: SIMPSON AM ILAND H CLARKE RA BURN AL TUCH BE
Citation: Am. Simpson et al., TRANSFORMATION OF PITUITARY AND FIBROBLAST CELL-LINES USING HUMAN INSULIN C-DNA AND A DEXAMETHASONE-INDUCIBLE PROMOTER, Transplantation proceedings, 25(5), 1993, pp. 2915-2916
ANOTHER PARVOVIRUS-B19 INFECTION OF A CHRONIC LYMPHATIC-LEUKEMIA PATIENT - REPLY
Authors: ILAND H
Citation: H. Iland, ANOTHER PARVOVIRUS-B19 INFECTION OF A CHRONIC LYMPHATIC-LEUKEMIA PATIENT - REPLY, Australian and New Zealand Journal of Medicine, 23(2), 1993, pp. 218-218
Risultati: 1-9 |